1. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance

   • Goli Samimi
   • Gerald Manorek
   • Stephen B. Howell

   Original Article 16 September 2004 Pages: 1 - 11

   

2. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil

   • Gabriella Calviello
   • Fiorella Di Nicuolo
   • Paola Palozza

   Original Article 10 September 2004 Pages: 12 - 20

   

3. Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts

   • Julie L. Eiseman
   • Jing Lan
   • Merrill J. Egorin

   Original Article 27 August 2004 Pages: 21 - 32

   

4. Phase I study of green tea extract in patients with advanced lung cancer

   • Scott A. Laurie
   • Vincent A. Miller
   • Kenneth K. Ng

   Original Article 07 August 2004 Pages: 33 - 38

5. A dose-finding and pharmacokinetic study of the matrix metalloproteinase inhibitor MMI270 (previously termed CGS27023A) with 5-FU and folinic acid

   • M. Eatock
   • J. Cassidy
   • C. Twelves

   Original Article 10 September 2004 Pages: 39 - 46

   

6. Cytotoxic activity of a new paclitaxel formulation, Pacliex, in vitro and in vivo

   • Saadia Hassan
   • Sumeer Dhar
   • Elin Lindhagen

   Original Article 20 July 2004 Pages: 47 - 54

   

7. Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients

   • Saik Urien
   • Etienne Brain
   • François Lokiec

   Original Article 28 July 2004 Pages: 55 - 60

   

8. Pharmacokinetics and neutrophil toxicity of paclitaxel orally administered in mice with recombinant interleukin-2

   • Candice Jamois
   • Emmanuelle Comets
   • Laurence Bonhomme-Faivre

   Original Article 16 September 2004 Pages: 61 - 71

   

9. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)

   • I. E. L. M. Kuppens
   • T. M. Bosch
   • J. H. M. Schellens

   Original Article 17 August 2004 Pages: 72 - 78

   

10. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca²⁺ homeostasis

    • Ming-Jie Liu
    • Zhao Wang
    • Qing-Yu Wu

    Original Article 14 September 2004 Pages: 79 - 90

    

11. A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors

    • A. S. T. Planting
    • P. Sonneveld
    • J. Verweij

    Clinical Trial Report 28 July 2004 Pages: 91 - 99